Patent details

Herbas

VPB

Print

EN | LT

LT - TAL-EFFEKTORNUKLEASE ZUM GEZIELTEN KNOCKOUT DES HIV-KOREZEPTORS CCR5

EN - TAL-EFFECTOR NUCLEASE FOR TARGETED KNOCKOUT OF THE HIV CO-RECEPTOR CCR5

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C12N 9/22
		C12N 15/90

European patent
(11)	Number of the document	3140398
(13)	Kind of document	T
(96)	European patent application number	15744474.6
	Date of filing the European patent application	2015-05-04
(97)	Date of publication of the European application	2017-03-15
(45)	Date of publication and mention of the grant of the patent	2019-08-28
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/DE2015/200295
	Date	2015-05-04

PCT application publication
(87)	Number	WO 2015/169314
	Date	2015-11-12

Priority applications
(30)	Number	Date	Country code
	102014106327	2014-05-07	DE

Inventors
(72)	MOCK, Ulrike, GB FEHSE, Boris, DE

Grantee
(73)	ADVANCED GENE & CELL TECHNOLOGIES LLC (AGCT LLC), 194291 Lunacharskogo str. 35-51, Saint-Petersburg, RU

Title
(54)	TAL-EFFEKTORNUKLEASE ZUM GEZIELTEN KNOCKOUT DES HIV-KOREZEPTORS CCR5
	TAL-EFFECTOR NUCLEASE FOR TARGETED KNOCKOUT OF THE HIV CO-RECEPTOR CCR5